In a Danish trial published Oct. 1, 2026, in JAMA Network Open, twice-weekly exercise during treatment before surgery for gastroesophageal cancer didn't raise the chance of having surgery, and 3-year survival was…
In a phase 3 trial published Oct. 28, 2026, in the Journal of Clinical Oncology, adding pembrolizumab to focused radiation for early lung cancer that wasn't operated on did not delay recurrence…
In the INFRONT-3 phase 3 trial, published in October 2026 in Alzheimer's & Dementia, latozinemab raised progranulin levels in people with frontotemporal dementia from GRN mutations, but didn't slow the disease over…
